NCT01988909View on ClinicalTrials.gov

WR 279,396 for the Treatment of Cutaneous Leishmaniasis

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

WR 279,396

Paromomycin + Gentamicin Topical Cream

Trial Locations (2)

75013

Groupe Hospitalier Pitié-Salpêtrière, Paris

75019

Centre d'investigations cliniques- Hopital Robert Debré, Paris

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01988909 - WR 279,396 for the Treatment of Cutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter